Product Code: ETC8849975 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The psoriasis therapeutics market in the Philippines is growing due to increasing awareness, improved access to dermatological treatments, and advancements in biologic therapies. While traditional topical treatments and phototherapy remain widely used, the demand for systemic therapies, including immunosuppressants and biologics, is rising. The market is supported by pharmaceutical companies investing in research and development, along with efforts from healthcare organizations to enhance patient education and early diagnosis.
The psoriasis therapeutics market in the Philippines is driven by the increasing prevalence of the condition, growing awareness, and advancements in treatment options. Biologic therapies, topical treatments, and phototherapy remain key treatment approaches, with pharmaceutical companies investing in research to enhance efficacy and minimize side effects. The government`s efforts to improve healthcare access and the availability of newer biologics are expected to support market growth. However, high treatment costs and limited reimbursement options pose challenges for patients seeking long-term therapy.
The psoriasis therapeutics market in the Philippines faces challenges such as limited access to advanced biologic treatments due to high costs and reimbursement restrictions. Many patients rely on traditional topical therapies, which may not be effective for severe cases. Additionally, there is a lack of awareness and misdiagnosis, leading to delayed treatment. The healthcare infrastructure, especially in rural areas, also presents barriers to specialized dermatological care.
The Philippines` psoriasis therapeutics market is witnessing steady growth due to the rising prevalence of psoriasis and increasing awareness about available treatment options. Investments in biologics and advanced systemic therapies are driving market expansion, with pharmaceutical companies introducing innovative formulations. The government`s efforts to integrate psoriasis treatment into public healthcare programs and the increasing availability of biosimilars provide further growth opportunities. Research and development investments in personalized medicine and targeted therapies are also expected to shape the market`s future.
The Philippine government, through the Department of Health (DOH) and Philippine Health Insurance Corporation (PhilHealth), has been implementing policies to improve access to psoriasis treatment. While psoriasis is not yet included in PhilHealths primary care benefit package, efforts are being made to expand coverage for chronic dermatological diseases. The Food and Drug Administration (FDA) regulates biologics and topical treatments, ensuring safety and efficacy. Additionally, advocacy groups and non-governmental organizations (NGOs) are working to raise awareness and push for better public healthcare support for psoriasis patients. However, high treatment costs and limited accessibility in rural areas remain challenges.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Psoriasis Therapeutics Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Psoriasis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Psoriasis Therapeutics Market - Industry Life Cycle |
3.4 Philippines Psoriasis Therapeutics Market - Porter's Five Forces |
3.5 Philippines Psoriasis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Psoriasis Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Philippines Psoriasis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Psoriasis Therapeutics Market Trends |
6 Philippines Psoriasis Therapeutics Market, By Types |
6.1 Philippines Psoriasis Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Psoriasis Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Psoriasis Therapeutics Market Revenues & Volume, By Plaque Psoriasis, 2021- 2031F |
6.1.4 Philippines Psoriasis Therapeutics Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2 Philippines Psoriasis Therapeutics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Philippines Psoriasis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Philippines Psoriasis Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Philippines Psoriasis Therapeutics Market Revenues & Volume, By Topical, 2021- 2031F |
7 Philippines Psoriasis Therapeutics Market Import-Export Trade Statistics |
7.1 Philippines Psoriasis Therapeutics Market Export to Major Countries |
7.2 Philippines Psoriasis Therapeutics Market Imports from Major Countries |
8 Philippines Psoriasis Therapeutics Market Key Performance Indicators |
9 Philippines Psoriasis Therapeutics Market - Opportunity Assessment |
9.1 Philippines Psoriasis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Psoriasis Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Philippines Psoriasis Therapeutics Market - Competitive Landscape |
10.1 Philippines Psoriasis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Philippines Psoriasis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |